Coronavirus monitoring in sewage research expanded and extended Since March 2020, RIVM has been working with the water boards in the Netherlands to monitor sewage for traces of the coronavirus SARS-CoV-2. The measurements are an important supplement to other COVID-19 studies.
Fewer cases, higher percentage of positive tests In the week of 31 March to 6 April, 48,186 people in the Netherlands received a positive test result for COVID-19. That is a decrease of 7% compared to the week before.
New hold on vaccination with AstraZeneca for people under 60 years The Ministry of Health, Welfare and Sport (VWS) has decided to stop vaccinating with the COVID-19 vaccine made by AstraZeneca for people under 60 (born in 1961 or later), effectively from now until Wednesday.
People born 1947-1951 invited for COVID-19 vaccination starting 6 April Starting Tuesday 6 April, the first people in the next age group will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1947 through 1951.
Single vaccination after COVID-19 infection within the past six months Starting today, people who tested positive for COVID-19 in the past six months can indicate when scheduling a vaccination appointment that they only want one vaccine dose.
Broad approach needed against pharmaceutical residues in environment We can all help to reduce pollution of the environment by pharmaceutical residues.
Icy air measurements Bernice Notenboom’s Arctic March expedition team has reached the summit of Greenland. She has conquered the 3500-metre high summit on Greenland with functioning air measuring equipment.
Vaccination using needles: there are alternatives Dr Hoang Hirschberg, employed at RIVM, has carried out PhD research into three alternatives for needle injections. She concluded that all alternatives have advantages and limitations.
Injection needles: fact-finding and risk assessment of excess adhesive Commissioned by the Dutch Health Care Inspectorate (IGZ), RIVM investigated whether excess adhesive is present in two types of injection needles from the Terumo Company (K-Pack II and Neolus).
Points of special interest in home treatment with complex medical technologies Patients are increasingly being treated with complex medical technologies in their own home. This offers great benefits, however, it also introduces risks.